Search terms
Results 1 - 10 of 34 - ordered by :
Pages: 1 2 3 4

The risk of death or recurrent MI after the discontinuation of clopidogrel was studied by multivariable Poisson regression models. Twelve months after the index MI, for patients treated only ...

European Heart Journal, Charlot, Mette, Nielsen, Lars Hougaard, Lindhardsen, Jesper, Ahlehoff, Ole, Olsen, Anne-Marie S., Hansen, Morten Lock, Hansen, Peter Riis, Madsen, Jan Kyst, Køber, Lars, ...

Date : 01/10/2012

The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: ...

European Heart Journal, Buch, Pernille, Rasmussen, Søren, Abildstrom, Steen Z., Køber, Lars, Carlsen, Jan, Torp-Pedersen, Christian

Date : 01/01/2005

The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic ...

European Heart Journal, Abdulla, Jawdat, Burchardt, Hans, Abildstrøm, Steen Z., Køber, Lars, Torp-Pedersen, Christian

Date : 01/12/2003

Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries Introduction Obesity is associated with an ...

European Heart Journal, Abdulla, Jawdat, Køber, Lars, Abildstrøm, Steen Z., Christensen, Erik, James, W. Philip T., Torp-Pedersen, Christian

Date : 01/03/2008

Background and scope of the problem Criteria have been established to define the occurrence of myocardial infarction (MI) or stroke in cardiovascular clinical trials, but a consensus definition has ...

European Heart Journal, Zannad, Faiez, Stough, Wendy Gattis, Pitt, Bertram, Cleland, John G.F., Adams, Kirkwood F., Geller, Nancy L., Torp-Pedersen, Christian, Kirwan, Bridget-Anne, Follath, Ferenc

Date : 01/02/2008 Item size : 352597 bytes

Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure Aims Atrial fibrillation (AF) is a risk factor for death in patients with a myocardial infarction, ...

European Heart Journal, Pedersen, Ole Dyg, Søndergaard, Peter, Nielsen, Tonny, Nielsen, Søren Junge, Nielsen, Eric Steen, Falstie-Jensen, Niels, Nielsen, Ingolf, Køber, Lars, Burchardt, ...

Date : 01/12/2006

Abstract Aims Family history is an established risk factor for myocardial infarction (MI), but it is not clear how this risk changes with number and gender of first-degree relatives with ...

European Heart Journal, Nielsen, Mia, Andersson, Charlotte, Gerds, Thomas A., Andersen, Per Kragh, Jensen, Thomas Bo, Køber, Lars, Gislason, Gunnar, Torp-Pedersen, Christian

Date : 21/04/2013 Item size : 173710 bytes

Carcinogenicity of cardiovascular drugs The article by Sipahi et al.1 reporting a small but significant risk of cancer associated with angiotensin receptor inhibitors was widely covered by news media ...

European Heart Journal, Messerli, Franz H., Bangalore, Sripal, Torp-Pedersen, Christian, Staessen, Jan A., Kostis, John B.

Date : 14/04/2013 Item size : 185920 bytes

Bleeding risks are typically dose related, making selection of the optimal dose (or preferably, doses) to advance from phase II to III testing a critical step in drug development.1 Efficacy is ...

European Heart Journal, Verheugt, Freek W.A., Clemmensen, Peter, Mehran, Roxana, Agewall, Stefan, Pocock, Stuart J., Goldstein, Sidney, Torp-Pedersen, Christian, Simoons, Maarten L., Borer, Jeffrey ...

Date : 07/06/2013

Abstract Aims The aim of this Danish nationwide study was to evaluate the treatment of myocardial infarction (MI) in patients with non-end-stage chronic kidney disease (CKD) and in patients requiring ...

European Heart Journal, Blicher, Thalia Marie, Hommel, Kristine, Olesen, Jonas Bjerring, Torp-Pedersen, Christian, Madsen, Mette, Kamper, Anne-Lise

Date : 01/10/2013 Item size : 310518 bytes